InsidersTradesSigma
HLB제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the HLB제약 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, HLB제약 has recorded 1 reports. Market capitalisation: €346.7bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: HLB제약. The full history is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Fundamental score
Ranked 20,163 of 26,211 companies
33.0
score / 100
Value25
Quality41
FCF yld-1.7%
Earn yld1.2%
EV/EBITDA42.0x
ROE-40%
Gross mgn52%
Net mgn2.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 March 2026